Thursday, February 09, 2006
If you want to make money invest in Cannabis drug comp.
GW Pharmaceuticals are now producing Sativex for many ailments including MS ...the stock price is around 120p but the potential is huge...could seriously damage the wealth of the big drug companies who pump out their bitter pills of deathForum post by mason-free party
For more information go to www.advfn.com and search GWP in quote box
GW pharmaceuticals is developing a portfolio of cannabis medicines the first of which, “Sativex®”, received an Approval with Conditions from Health Canada in April 2005 for use as an adjunctive treatment for the symptom relief of neuropathic pain in Multiple Sclerosis (MS). Sativex® was launched in Canada in June 2005.
A fact sheet, “Dear Healthcare Provider” letter and product monograph for Sativex® are now available via the Bayer Canada website. These documents are intended for use only by patients and healthcare professionals in Canada.
For any other enquiries please use the contact details below.
Canadian Enquiries:
For enquiries regarding Sativex® in Canada please contact Bayer Canada, GW’s marketing partner for Canada:
Tel: (1) 800 265 7382
Fax: (1) 866 232 0565
E-mail canada.medinfo@bayer.com
UK Enquiries:
For enquiries regarding Sativex® in the UK please contact Bayer Healthcare, GW’s marketing partner for the UK:
Direct Tel during working hours (9am-12:30pm, 1:30-5pm) 01635 563116
Direct Fax 01635 563657
Switchboard 01635 563000
E-mail medical.science@bayer.co.uk
Urgent Enquiries (between 12:30 - 13:30)
07876 577704
Out of hours enquiries 01635 563000
Interesting. It's mentioned that synthetic THC hasn't helped Cancer and AIDS patients. Best form is probably the natural stuff by inhaler. The economic advice is not mine. I'm just resposting this from a forum topic.
